China Computed Tomography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China Computed Tomography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China computed tomography (CT) market was valued at USD 1,113.56 million in 2021 and is projected to register a CAGR of 6.48% during the forecast period (2022-2027).

During the early stages of the pandemic, the Chinese government imposed a state-wide public transportation freeze, effectively halting all diagnostic department operations. Patients for imaging and therapy in the cardiovascular, dental, oncology, and orthopedic departments were drastically reduced, and procedures were postponed until the situation returned to normal. In the case of government hospitals, diagnostic department workers were reallocated to alternative departments such as logistics and triage, and some imaging services and clinics were closed across the country. Hence, COVID-19 had significantly affected the market for computer tomography in China. As per the article published in May 2020 by the National Institute of Health titled, 'CT and COVID-19: Chinese experience and recommendations concerning detection, staging, and follow-up,' even before getting the RT-PCR testing, the National Health Commission of the People's Republic of China included a CT scan as a key diagnostic tool in its fifth version of diagnosis and treatment for COVID-19. This has helped the market study grow in China during the COVID-19 outbreak.

Factors, such as the growing burden of chronic diseases and technological advancements in computed tomography are expected to drive the market in the forecast period. China has offered many opportunities to the key players in the industry. Therefore, many foreign players are trying to establish their presence in the Chinese market. For instance, in September 2021, Tencent obtained a Class III medical device license for its pneumonia CT imaging software to support triage and assessment, becoming the first internet company in China to obtain a Class III AI medical license. Various strategic initiatives are being undertaken by the major players. These include mergers, acquisitions, collaborations, partnerships, and product launches. For instance, in February 2020, Samsung Neurologica dedicated resources to accelerating the production of mobile computed tomography production for coronavirus scanning in China.

Similarly, expansion by the key market player in the facility of manufacturing digital radiographs is expected to boost the market in the country, for instance, In July 2021, FUJIFILM presented the idea of smart imaging and smart hospital in China. In terms of smart imaging, Fujifilm (China) integrated advanced IT technologies such as the Internet, the Internet of Things, sensors, chips, and algorithms with its years of accumulation in medical imaging fields such as X-ray, nuclear magnetic, computed tomography, ultrasound, and optics. Hence, owing to these factors, the studied market is expected to witness significant growth in the country.

Key Market TrendsDiagnostic Centers to Hold Significant Share in End-User Segment

Diagnostic centers are the major end users of computed tomography and are expected to witness a significant share in the segment.

Factors such as the high frequency of dental and cardiovascular ailments, orthopedic diseases, cancer, and strategic efforts by leading companies, as well as huge investments in the healthcare industry, are likely to drive the segment growth. Additionally, market growth is projected to be aided by population awareness of CT imaging services.

Strategic collaboration and partnership in the segment impel the market growth in the country. For instance, in April 2021, AstraZeneca and Geneseeq Technology Inc. collaborated strategically to establish the Bio-Diagnostic Innovation Center in China. The collaboration also includes establishing a clinical diagnostics laboratory for creating an integrated and patient-centric disease diagnosis, treatment, and rehabilitation for cancer patients.

Similarly, in September 2020, Guangzhou-based Perception Vision Medical Technology Company (PVmed) and Boston, US-based RADLogics entered into a strategic partnership to develop a long-term business relationship in terms of resources, marketing, technology, and global expansion to explore a new age of AI-enabled medical imaging. With over a decade of experience, RADLogics has deployed its solution globally and processed millions of CT and X-ray scans from clinical sites in the United States, Europe, Russia, China, and India.

Hence, with the above-mentioned factors, the diagnostic centers are believed to play crucial role in the computed tomography market in China.

Competitive Landscape

China computed tomography (CT) market is consolidated due to the presence of a few major players, including Canon Medical Systems Corporation, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers. These major players hold a significant share in the industry. Most of the players focus on bringing technologically advanced products into the market to acquire the maximum market share.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.